SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328951. A total of 2 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $26,000 | -3.7% | 46,700 | -6.4% | 0.00% | – |
| Q1 2016 | $27,000 | -64.9% | 49,900 | -42.2% | 0.00% | -100.0% |
| Q4 2015 | $77,000 | +97.4% | 86,300 | +77.2% | 0.00% | 0.0% |
| Q3 2015 | $39,000 | -67.8% | 48,700 | +21.4% | 0.00% | -50.0% |
| Q2 2015 | $121,000 | -19.3% | 40,100 | -34.6% | 0.00% | 0.0% |
| Q1 2015 | $150,000 | -33.6% | 61,300 | -30.8% | 0.00% | -33.3% |
| Q4 2014 | $226,000 | -93.2% | 88,600 | -81.1% | 0.00% | -94.2% |
| Q3 2014 | $3,347,000 | +346.9% | 468,700 | +308.3% | 0.05% | +333.3% |
| Q2 2014 | $749,000 | +10.0% | 114,800 | +11.3% | 0.01% | +9.1% |
| Q1 2014 | $681,000 | +1035.0% | 103,100 | +711.8% | 0.01% | +1000.0% |
| Q4 2013 | $60,000 | +2900.0% | 12,700 | +3075.0% | 0.00% | – |
| Q3 2013 | $2,000 | -99.4% | 400 | -99.3% | 0.00% | -100.0% |
| Q2 2013 | $312,000 | – | 59,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|